-
EP0973748
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0973748
| EP0973748 - METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 23.03.2007 Database last updated on 20.12.2024 | Most recent event Tooltip | 23.03.2007 | Application deemed to be withdrawn | published on 25.04.2007 [2007/17] | Applicant(s) | For all designated states Agouron Pharmaceuticals, Inc. 10777 Science Center Drive San Diego California 92121 / US | [N/P] |
| Former [2004/35] | For all designated states Agouron Pharmaceuticals, Inc. 10777 Science Center Drive San Diego, California 92121 / US | ||
| Former [2000/04] | For all designated states AGOURON PHARMACEUTICALS, INC. 10350 North Torrey Pines Road La Jolla, CA 92037-1022 / US | Inventor(s) | 01 /
BENDER, Steven, L. 606 Eucalyptus Street Oceanside, CA 92054 / US | 02 /
ABREO, Melwyn, A. 460 Bonito Avenue Imperial Beach, CA 91932 / US | [2000/04] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
| Former [2000/04] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | Application number, filing date | 98914379.7 | 31.03.1998 | [2000/04] | WO1998US06365 | Priority number, date | US19970825318 | 01.04.1997 Original published format: US 825318 | [2000/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9843963 | Date: | 08.10.1998 | Language: | EN | [1998/40] | Type: | A1 Application with search report | No.: | EP0973748 | Date: | 26.01.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.10.1998 takes the place of the publication of the European patent application. | [2000/04] | Search report(s) | International search report - published on: | EP | 08.10.1998 | Classification | IPC: | C07D233/54, C07D213/32, C07D261/10, C07C323/57, C07C311/29, C07D213/68, C07D213/12, C07D213/64, C07D405/12, C07D213/34, A61K31/44, A61K31/195, A61K31/41 | [2000/04] | CPC: |
C07D213/643 (EP);
C07C311/16 (KR);
A61P1/02 (EP);
A61P13/00 (EP);
A61P17/00 (EP);
A61P19/02 (EP);
A61P19/10 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P35/04 (EP);
A61P43/00 (EP);
A61P9/10 (EP);
C07C311/29 (EP);
C07C323/52 (EP);
C07C323/60 (EP);
C07D213/32 (EP);
C07D213/34 (EP);
C07D213/68 (EP);
C07D213/70 (EP);
C07D233/64 (EP);
C07D261/08 (EP);
C07D405/12 (EP);
C07D413/12 (EP)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/04] | Title | German: | IHRE PHARMAZEUTISCHE ANWENDUNGENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND IHRE PHARMAZEUTISCHE ANWENDUNG | [2000/04] | English: | METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES | [2000/04] | French: | INHIBITEURS DE METALLOPROTEINASES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEURS UTILISATIONS PHARMACEUTIQUES | [2000/04] | Entry into regional phase | 28.10.1999 | National basic fee paid | 28.10.1999 | Designation fee(s) paid | 28.10.1999 | Examination fee paid | Examination procedure | 28.10.1998 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.10.1999 | Examination requested [2000/04] | 04.03.2003 | Despatch of a communication from the examining division (Time limit: M04) | 14.07.2003 | Reply to a communication from the examining division | 06.08.2004 | Despatch of a communication from the examining division (Time limit: M04) | 15.12.2004 | Reply to a communication from the examining division | 13.07.2005 | Despatch of a communication from the examining division (Time limit: M06) | 22.11.2005 | Reply to a communication from the examining division | 03.10.2006 | Application deemed to be withdrawn, date of legal effect [2007/17] | 10.11.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2007/17] | Fees paid | Renewal fee | 06.03.2000 | Renewal fee patent year 03 | 08.03.2001 | Renewal fee patent year 04 | 22.03.2002 | Renewal fee patent year 05 | 24.02.2003 | Renewal fee patent year 06 | 22.03.2004 | Renewal fee patent year 07 | 22.03.2005 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.03.2006 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9535276 (BRITISH BIOTECH PHARM [GB], et al) [A] 1,11-24 * see page 3, last paragraph; page 16, line17 - page 19, line 7; examples; claims *; | [AD]WO9627583 (PFIZER [US], et al) [AD] 1,11-24 * see page 10, lines 8-10; page 11, line 7 - page 12, line 2; page 27, line 7 - page 33, line 19; claims 1-17 *; | [A]EP0757984 (ONO PHARMACEUTICAL CO [JP]) [A] 1,11-20,22,23 * see page 42, line 46 - page 44, line 14; claims 1-8 *; | [PX]WO9727174 (SHIONOGI & CO [JP], et al) [PX] 1,2,4,7,9,11-13,20,22,23 * see abstract; pages 50-52, compounds 60-70 *; | [PX]WO9720824 (AGOURON PHARMA [US], et al) [PX] 1-5,7,9 * see example 16, step 1 * | [ ] - DATABASE WPI, 1, Derwent World Patents Index, vol. 97, no. 36, Database accession no. 97-393586, XP002069234 [ ] * abstract * |